| Health / Medical Topics |
AKT Inhibitor ARQ 092
An orally bioavailable inhibitor of the serine/threonine protein kinase AKT (protein kinase B) with potential antineoplastic activity. AKT inhibitor ARQ 092 binds to and inhibits the activity of AKT in a non-ATP competitive manner, which may result in the inhibition of the PI3K/AKT signaling pathway. This may lead to the reduction in tumor cell proliferation and the induction of tumor cell apoptosis. The AKT signaling pathway is often deregulated in cancer and is associated with tumor cell proliferation, survival and migration. (NCI Thesaurus)
YOU MAY ALSO LIKE
A molecular genetic abnormality indicating the presence of mutations in the AKT family of genes. This family includes the AKT1, AKT2,…
An orally bioavailable inhibitor of the serine/threonine protein kinase AKT (protein kinase B) isoforms 1 and 2 (AKT1/2) with potential antineoplastic…
A group of enzymes involved in several processes related to cell growth and survival. Akt enzymes help to transfer signals inside…
A British Overseas Territory comprising a peninsula on the southern coast of Cyprus.
Human AKR7A2 wild-type allele is located within 1p35.1-p36.23 and is approximately 8 kb in length. This allele, which encodes aflatoxin B1 aldehyde…
This gene is involved in the detoxification of xenobiotics.
